Gwenn Hansen
Chief Tech/Sci/R&D Officer at NURIX THERAPEUTICS, INC.
Net worth: 535 109 $ as of 30/03/2024
Profile
Gwenn M.
Hansen is currently the Chief Scientific Officer at Nurix Therapeutics, Inc. She started this position in 2020.
Previously, she worked as an Associate Professor at Baylor College of Medicine.
Dr. Hansen completed her undergraduate degree at Gustavus Adolphus College and obtained her doctorate from the University of Tennessee.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
NURIX THERAPEUTICS, INC.
0.07% | 20/03/2024 | 36,402 ( 0.07% ) | 535 109 $ | 30/03/2024 |
Gwenn Hansen active positions
| Companies | Position | Start |
|---|---|---|
| NURIX THERAPEUTICS, INC. | Chief Tech/Sci/R&D Officer | 30/06/2019 |
Former positions of Gwenn Hansen
| Companies | Position | End |
|---|---|---|
| Baylor College of Medicine | Corporate Officer/Principal | - |
Training of Gwenn Hansen
| Gustavus Adolphus College | Undergraduate Degree |
| University of Tennessee | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| NURIX THERAPEUTICS, INC. | Health Technology |
- Stock Market
- Insiders
- Gwenn Hansen
